A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes

Clinical trial NCT00675857 · COMPLETED

Trial details

NCT number: NCT00675857
Sponsor: Bellus Health Inc. - a GSK company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Metabolic Syndrome X

Start date: 2008-04-01
Primary completion: 2010-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.